Oxypro 60mg modified-release tablets
BNF presentation 0407020ADBSAGAQ within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBSAGAQ
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
2,471
NHS spend (£)
£70,220.24
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 430 |
| February 2025 | 2 |
| December 2024 | 116 |
| November 2024 | 441 |
| October 2024 | 441 |
| September 2024 | 3 |
| August 2024 | 18 |
| July 2024 | 463 |
| May 2024 | 86 |
| July 2021 | 78 |
| June 2021 | 58 |
| December 2020 | 151 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 49 | No data available |
|
James Street Group Pract
ODS A82047
|
44 | 01H - NORTH EAST AND NORTH CUMBRIA ICB |
| Unknown pharmacy | 38 | No data available |
|
Ponteland Medical Group
ODS A84007
|
32 | 00L - NORTH EAST AND NORTH CUMBRIA ICB |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 24 | No data available |
| Unknown pharmacy | 23 | No data available |
| Unknown pharmacy | 21 | No data available |
| Unknown pharmacy | 20 | No data available |